Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata in Movement Initiation and Perception

NCT02216435 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02216435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02216435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata in Movement Initiation and Perception
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
February 22, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease